JP2022519570A5 - - Google Patents
Info
- Publication number
- JP2022519570A5 JP2022519570A5 JP2021544796A JP2021544796A JP2022519570A5 JP 2022519570 A5 JP2022519570 A5 JP 2022519570A5 JP 2021544796 A JP2021544796 A JP 2021544796A JP 2021544796 A JP2021544796 A JP 2021544796A JP 2022519570 A5 JP2022519570 A5 JP 2022519570A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- approximately
- formulation according
- fusion protein
- solution formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024174033A JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1901547.8 | 2019-02-05 | ||
| GBGB1901547.8A GB201901547D0 (en) | 2019-02-05 | 2019-02-05 | Stabilized Fc Fusion protein solutions |
| PCT/GB2020/050255 WO2020161487A1 (en) | 2019-02-05 | 2020-02-05 | STABILIZED Fc FUSION PROTEIN SOLUTIONS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174033A Division JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519570A JP2022519570A (ja) | 2022-03-24 |
| JP2022519570A5 true JP2022519570A5 (https=) | 2023-02-14 |
Family
ID=65996928
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544796A Pending JP2022519570A (ja) | 2019-02-05 | 2020-02-05 | 安定化Ｆｃ融合タンパク質溶液 |
| JP2024174033A Pending JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024174033A Pending JP2025020122A (ja) | 2019-02-05 | 2024-10-03 | 安定化Ｆｃ融合タンパク質溶液 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220125718A1 (https=) |
| EP (1) | EP3921340A1 (https=) |
| JP (2) | JP2022519570A (https=) |
| GB (1) | GB201901547D0 (https=) |
| WO (1) | WO2020161487A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250056816A (ko) * | 2023-10-18 | 2025-04-28 | 주식회사 엘지화학 | Affimer의 안정화 제형 및 그의 제조 방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1478394T1 (sl) | 2002-02-27 | 2008-12-31 | Immunex Corp | STABILIZIRAN TNFR-Fc SESTAVEK Z ARGININOM |
| BR112012017982A2 (pt) * | 2010-01-19 | 2016-05-03 | Hanmi Science Co Ltd | formulações líquidas para conjugado de eritropoietina de longa ação |
| EP2699265B1 (en) | 2011-04-20 | 2019-10-16 | Sandoz AG | STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc |
| CN103930124B (zh) | 2011-07-01 | 2021-05-11 | 生物基因Ma公司 | 无精氨酸的tnfr：fc-融合多肽组合物及使用方法 |
| US10485869B2 (en) * | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
| WO2014078627A1 (en) * | 2012-11-19 | 2014-05-22 | Merck Sharp & Dohme Corp. | Liquid formulations for tnfr:fc fusion proteins |
| CN104870019A (zh) * | 2012-11-27 | 2015-08-26 | 阿特根公司 | 用于稳定蛋白质和Fc结构域融合的融合蛋白的组合物 |
| CN105873601A (zh) * | 2013-05-02 | 2016-08-17 | 马柏克辛斯公司 | TNFR:Fc融合多肽的替代配方 |
| WO2015080513A1 (en) * | 2013-11-29 | 2015-06-04 | Hanwha Chemical Corporation | A liquid formulation of a fusion protein comprising tnfr and fc region |
-
2019
- 2019-02-05 GB GBGB1901547.8A patent/GB201901547D0/en not_active Ceased
-
2020
- 2020-02-05 EP EP20705472.7A patent/EP3921340A1/en active Pending
- 2020-02-05 US US17/428,341 patent/US20220125718A1/en active Pending
- 2020-02-05 WO PCT/GB2020/050255 patent/WO2020161487A1/en not_active Ceased
- 2020-02-05 JP JP2021544796A patent/JP2022519570A/ja active Pending
-
2024
- 2024-10-03 JP JP2024174033A patent/JP2025020122A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2833427C (en) | Stable pharmaceutical liquid formulations of the fusion protein tnfr:fc | |
| JP5918850B2 (ja) | エタネルセプトの安定した液状製剤 | |
| KR102482664B1 (ko) | 신규한 제제 | |
| US12251474B2 (en) | Process for lyophilized pharmaceutical formulations of a therapeutic protein | |
| JP2013521296A5 (https=) | ||
| JP2020063261A (ja) | ＴＮＦＲ及びＦｃ領域を含む融合タンパク質の液体製剤 | |
| CA2794929A1 (en) | Concentrated protein formulations and uses thereof | |
| JP2019533656A5 (https=) | ||
| US20170189528A1 (en) | Stable aqueous adalimumab formulation | |
| KR102276304B1 (ko) | 지속형 인간 성장 호르몬 제제 | |
| RU2756619C2 (ru) | Жидкая композиция антитела против TNF альфа | |
| JP2020508331A5 (https=) | ||
| JP7730882B2 (ja) | 水性医薬製剤 | |
| JP2022519570A5 (https=) | ||
| US20260069688A1 (en) | Stable antibody composition | |
| JP2025020122A (ja) | 安定化Ｆｃ融合タンパク質溶液 | |
| KR102692727B1 (ko) | 수성 제제 및 주사기 내 수성 제제, 및 항체 단백질 탈응집제 및 항체 단백질 탈응집 방법 | |
| KR20160045608A (ko) | 단백질 안정화용 조성물 및 이를 포함하는 약제학적 제제 | |
| JP2018150258A (ja) | 水性製剤、注射器入り水性製剤及びキット製剤 | |
| KR102954604B1 (ko) | 인간 부갑상선 호르몬(pth)의 제형 및 그 제조 방법 | |
| KR102844063B1 (ko) | 혼성 fc 융합된 g-csf를 위한 안정한 동결 건조 제형 | |
| WO2021195877A1 (en) | Formulations of human parathyroid hormone (pth) and methods for producing same | |
| HK40033832B (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| HK40033832A (en) | Process for lyophilized pharmaceutical formulation of a therapeutic protein | |
| BR112020004902B1 (pt) | Processo para formulação farmacêutica liofilizada de uma proteína terapêutica |